To determine the efficacy of sclerotherapy for venous malformations (VMs).
Methods:
PubMed was used to search the medical literatures for publication on the combined topics of “VMs and sclerotherapy.” The final evaluation of the venous lesions was based on both objective parameters and subjective parameters. Complications were also recorded.
Results:
A total of 35 studies published between 1986 and 2011 matched the selection criteria and were included. Ethanol, polidocanol, ethanolamine oleate, and sodium tetradecyl sulfate (STS) are the 4 mainstream sclerosants. The total efficiency of these 4 sclerosants all exceeded 90% except STS. Skin damage (10.0%) was the most common minor complication. Other complications included renal damage (3.9%), nerve damage (1.85%), muscle damage (0.66%), pulmonary embolism (0.25%), cardiovascular collapse (0.08%), and others.
Conclusions:
Sclerotherapy is effective for VMs. However, there is limited evidence from randomized clinical trials to support the use of any kinds of sclerosants.
LegiehnGMHeranMK.Venous malformations: classification, development, diagnosis, and interventional radiologic management.Radiol Clin North Am.2008;46(3):545–597, vi.
2.
DuboisJSoulezGOlivaVLBerthiaumeMJLapierreCTherasseE. Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. Radiographics. 2001;21(6):1519–1531.
3.
CostaJRTorrianiMAHosniESD'AvilaOPde FigueiredoPJ. Sclerotherapy for vascular malformations in the oral and maxillofacial region: treatment and follow-up of 66 lesions. J Oral Maxillofac Surg. 2011;69(6):e88–e92.
4.
DompmartinABlaizotXThéronJ. Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations. Eur Radiol. 2011;21(12):2647–2656.
5.
SannierKDompmartinAThéronJ. A new sclerosing agent in the treatment of venous malformations. Study on 23 cases.Interv Neuroradiol.2004;10(2):113–127.
6.
SpenceJKringsTTerBruggeKGAgidR. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy. Head Neck. 2011;33(1):125–130.
7.
OrlandoJLCaldasJGCamposHGNishinariKWoloskerN. Outpatient percutaneous treatment of deep venous malformations using pure ethanol at low doses under local anesthesia. Clinics (Sao Paulo). 2011;65(9):837–840.
8.
BaekHJHongJPChoiJWSuhDC. Direct percutaneous alcohol sclerotherapy for venous malformations of head and neck region without fluoroscopic guidance: technical consideration and outcome. Neurointervention. 2011;6(2):84–88.
9.
SuLFanXZhengLZhengJ. Absolute ethanol sclerotherapy for venous malformations in the face and neck. J Oral Maxillofac Surg. 2010;68(7):1622–1627.
10.
OrlandoJLCaldasJGCamposHGNishinariKWoloskerN. Ethanol sclerotherapy of superficial venous malformation: a new procedure. Dermatology. 2010;220(4):376–380.
11.
IerardiAMManginiMVaghiMCazzulaniACarrafielloGMattassiR. Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications. Vasc Endovascular Surg. 2010;44(4):282–288.
12.
LeeIHKimKHJeonP. Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results. Korean J Radiol. 2009;10(3):269–276.
13.
LeeCHChenSG. Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck. Br J Plast Surg. 2005;58(8):1073–1078.
LeeBBDoYSByunHSChooIWKimDIHuhSH. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg. 2003;37(3):533–538.
16.
JohnsonPLEckardDABrecheisenMAGirodDATsueTT. Percutaneous ethanol sclerotherapy of venous malformations of the tongue. AJNR Am J Neuroradiol. 2002;23(5):779–782.
17.
ShiremanPKMcCarthyWJYaoJSVogelzangRL. Treatment of venous malformations by direct injection with ethanol. J Vasc Surg. 1997;26(5):838–844.
18.
BerthelsenBFogdestamISvendsenP.Venous malformations in the face and neck. Radiologic diagnosis and treatment with absolute ethanol. Acta Radiol Diagn (Stockh). 1986;27(2):149–155.
19.
HoqueSDasBK. Treatment of venous malformations with ethanolamine oleate: a descriptive study of 83 cases. Pediatr Surg Int. 2011;27(5):527–531.
20.
KajiNKuritaMOzakiM. Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck. Scand J Plast Reconstr Surg Hand Surg. 2009;43(3):126–136.
21.
JohannACAguiarMCdo CarmoMAGomezRSCastroWHMesquitaRA. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100(5):579–584.
22.
KimKHSungMWRohJLHanMH. Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg. 2004;131(3):307–316.
23.
BonanPRMiranda LdePMendesDCde PaulaAMPegoSPMartelli-JuniorH. Effectiveness of low flow vascular lesions sclerosis with monoethanolamine: report of six cases. Med Oral Patol Oral Cir Bucal. 2007;12(7):E524–E527.
24.
BlaiseSCharavin-CocuzzaMRiomH. Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review. Eur J Vasc Endovasc Surg. 2011;41(3):412–417.
25.
YamakiTNozakiMSakuraiHTakeuchiMSoejimaKKonoT. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg. 2008;47(3):578–584.
26.
MimuraHKanazawaSYasuiK. Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy. Acta Med Okayama. 2003;57(5):227–234.
27.
CabreraJCabreraJJrGarcia-OlmedoMARedondoP. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139(11):1409–1416.
28.
JainRBandhuSSawhneySMittalR. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations. J Clin Ultrasound. 2002;30(7):416–423.
29.
Marrocco-TrischittaMMNicodemiEMStilloF. Sclerotherapy for venous malformations of the glans penis. Urology. 2001;57(2):310–313.
30.
YamakiTNozakiMSasakiK. Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg. 2000;26(4):323–328.
31.
KrokidisMVenetucciPHatzidakisAIaccarinoV. Sodium tetradecyl sulphate direct intralesional sclerotherapy of venous malformations of the vulva and vagina: report of five cases. Cardiovasc Intervent Radiol. 2011;34(suppl 2):S228–S231.
32.
KhandpurSSharmaVK. Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations. Dermatol Surg. 2010;36(3):340–346.
33.
TanKTKirbyJRajanDKHayeemsEBeecroftJRSimonsME. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience. J Vasc Interv Radiol. 2007;18(3):343–351.
34.
MaheshBThulkarSJosephGKhazanchiRKSrivastavaA. Colour duplex ultrasound-guided sclerotherapy: a new approach to the management of patients with peripheral vascular malformations. Clin Imaging. 2003;27(3):171–179.
35.
SiniluotoTMSvendsenPAWikholmGMFogdestamIEdstromS. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol). Scand J Plast Reconstr Surg Hand Surg. 1997;31(2):145–150.
36.
LiLZengXQLiYH. Digital subtraction angiography-guided foam sclerotherapy of peripheral venous malformations. AJR Am J Roentgenol. 2010;194(5):W439–W444.
37.
LiLFengJZengXQLiYH. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: preliminary experience. J Vasc Surg. 2009;49(4):961–967.
38.
SpenceJKringsTterBruggeKGda CostaLBAgidR. Percutaneous sclerotherapy for facial venous malformations: subjective clinical and objective MR imaging follow-up results. AJNR Am J Neuroradiol. 2010;31(5):955–960.
39.
ZhiKWenYLiLRenW. The role of intralesional Pingyangmycin in the treatment of venous malformation of facial and maxillary region. Int J Pediatr Otorhinolaryngol. 2008;72(5):593–597.
40.
RosbeKWHessCPDowdCFFriedenIJ. Masseteric venous malformations: diagnosis, treatment, and outcomes. Otolaryngol Head Neck Surg. 2011;143(6):779–783.
41.
Berenguer B BurrowsPE ZurakowskiDMulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results.Plast Reconstr Surg.1999;104(1):1–11; discussion 12-15.
42.
PrasetyonoTOKreshantiP. Efficacy of intra-lesional alcohol injection as alternative and/or complementary treatment of vascular malformations: a systematic review. J Plast Reconstr Aesthet Surg. 2010;63(7):1071–1079.
